目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Immunotherapy Drugs Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Immunotherapy Drugs Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape.
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape

Chapter 4. Immunotherapy Drugs Market: Drug Type Estimates & Trend Analysis
4.1. Drug Type Market Share, 2024 & 2030
4.2. Drug Type Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Drug Type, 2018 to 2030 (USD Million)
4.4. Monoclonal Antibodies
4.4.1. Monoclonal Antibodies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Immunomodulator
4.5.1. Immunomodulator Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Vaccine
4.6.1. Vaccine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Immunotherapy Drugs Market: Indication Estimates & Trend Analysis
5.1. Indication Market Share, 2024 & 2030
5.2. Indication Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Drug Type, 2018 to 2030 (USD Million)
5.4. Cancer
5.4.1. Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Autoimmune Diseases
5.5.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Infectious Diseases
5.6.1. Infectious Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Others
5.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Immunotherapy Drugs Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
6.4. North America
6.4.1. North America Immunotherapy Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.2. U.S.
6.4.2.1. Key Country Dynamics
6.4.2.2. Regulatory Framework
6.4.2.3. Competitive Insights
6.4.2.4. U.S. Immunotherapy Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.3. Canada
6.4.3.1. Key Country Dynamics
6.4.3.2. Regulatory Framework
6.4.3.3. Competitive Insights
6.4.3.4. Canada Immunotherapy Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.4. Mexico
6.4.4.1. Key Country Dynamics
6.4.4.2. Regulatory Framework
6.4.4.3. Competitive Insights
6.4.4.4. Mexico Immunotherapy Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Europe
6.5.1. Europe Immunotherapy Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.2. UK
6.5.2.1. Key Country Dynamics
6.5.2.2. Regulatory Framework
6.5.2.3. Competitive Insights
6.5.2.4. UK Immunotherapy Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. Germany
6.5.3.1. Key Country Dynamics
6.5.3.2. Regulatory Framework
6.5.3.3. Competitive Insights
6.5.3.4. Germany Immunotherapy Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.4. France
6.5.4.1. Key Country Dynamics
6.5.4.2. Regulatory Framework
6.5.4.3. Competitive Insights
6.5.4.4. France Immunotherapy Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.5. Italy
6.5.5.1. Key Country Dynamics
6.5.5.2. Regulatory Framework
6.5.5.3. Competitive Insights
6.5.5.4. Italy Immunotherapy Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.6. Spain
6.5.6.1. Key Country Dynamics
6.5.6.2. Regulatory Framework
6.5.6.3. Competitive Insights
6.5.6.4. Spain Immunotherapy Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.7. Denmark
6.5.7.1. Key Country Dynamics
6.5.7.2. Regulatory Framework
6.5.7.3. Competitive Insights
6.5.7.4. Denmark Immunotherapy Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.8. Sweden
6.5.8.1. Key Country Dynamics
6.5.8.2. Regulatory Framework
6.5.8.3. Competitive Insights
6.5.8.4. Sweden Immunotherapy Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.9. Norway
6.5.9.1. Key Country Dynamics
6.5.9.2. Regulatory Framework
6.5.9.3. Competitive Insights
6.5.9.4. Norway Immunotherapy Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Asia Pacific
6.6.1. Asia Pacific Immunotherapy Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.2. Japan
6.6.2.1. Key Country Dynamics
6.6.2.2. Regulatory Framework
6.6.2.3. Competitive Insights
6.6.2.4. Japan Immunotherapy Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.3. China
6.6.3.1. Key Country Dynamics
6.6.3.2. Regulatory Framework
6.6.3.3. Competitive Insights
6.6.3.4. China Immunotherapy Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.4. India
6.6.4.1. Key Country Dynamics
6.6.4.2. Regulatory Framework
6.6.4.3. Competitive Insights
6.6.4.4. India Immunotherapy Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.5. Thailand
6.6.5.1. Key Country Dynamics
6.6.5.2. Regulatory Framework
6.6.5.3. Competitive Insights
6.6.5.4. Thailand Immunotherapy Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.6. South Korea
6.6.6.1. Key Country Dynamics
6.6.6.2. Regulatory Framework
6.6.6.3. Competitive Insights
6.6.6.4. South Korea Immunotherapy Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.7. Australia
6.6.7.1. Key Country Dynamics
6.6.7.2. Regulatory Framework
6.6.7.3. Competitive Insights
6.6.7.4. Australia Immunotherapy Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Latin America
6.7.1. Latin America Immunotherapy Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.2. Brazil
6.7.2.1. Key Country Dynamics
6.7.2.2. Regulatory Framework
6.7.2.3. Competitive Insights
6.7.2.4. Brazil Immunotherapy Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.3. Argentina
6.7.3.1. Key Country Dynamics
6.7.3.2. Regulatory Framework
6.7.3.3. Competitive Insights
6.7.3.4. Argentina Immunotherapy Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. Middle East and Africa
6.8.1. Middle East and Africa Immunotherapy Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.2. South Africa
6.8.2.1. Key Country Dynamics
6.8.2.2. Regulatory Framework
6.8.2.3. Competitive Insights
6.8.2.4. South Africa Immunotherapy Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Key Country Dynamics
6.8.3.2. Regulatory Framework
6.8.3.3. Competitive Insights
6.8.3.4. Saudi Arabia Immunotherapy Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.4. UAE
6.8.4.1. Key Country Dynamics
6.8.4.2. Regulatory Framework
6.8.4.3. Competitive Insights
6.8.4.4. UAE Immunotherapy Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.5. Kuwait
6.8.5.1. Key Country Dynamics
6.8.5.2. Regulatory Framework
6.8.5.3. Competitive Insights
6.8.5.4. Kuwait Immunotherapy Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape
7.1. Participant Overview
7.2. Company Market Position Analysis
7.3. Company Categorization
7.4. Strategy Mapping
7.5. Company Profiles/Listing
7.5.1. Amgen Inc.
7.5.1.1. Participant’s Overview
7.5.1.2. Financial Performance
7.5.1.3. Product Benchmarking
7.5.1.4. Recent Developments/ Strategic Initiatives
7.5.2. Novartis AG
7.5.2.1. Participant’s Overview
7.5.2.2. Financial Performance
7.5.2.3. Product Benchmarking
7.5.2.4. Recent Developments/ Strategic Initiatives
7.5.3. AbbVie Inc.
7.5.3.1. Participant’s Overview
7.5.3.2. Financial Performance
7.5.3.3. Product Benchmarking
7.5.3.4. Recent Developments/ Strategic Initiatives
7.5.4. Pfizer Inc.
7.5.4.1. Participant’s Overview
7.5.4.2. Financial Performance
7.5.4.3. Product Benchmarking
7.5.4.4. Recent Developments/ Strategic Initiatives
7.5.5. F. Hoffmann-La Roche Ltd
7.5.5.1. Participant’s Overview
7.5.5.2. Financial Performance
7.5.5.3. Product Benchmarking
7.5.5.4. Recent Developments/ Strategic Initiatives
7.5.6. Johnson & Johnson Services, Inc.
7.5.6.1. Participant’s Overview
7.5.6.2. Financial Performance
7.5.6.3. Product Benchmarking
7.5.6.4. Recent Developments/ Strategic Initiatives
7.5.7. AstraZeneca
7.5.7.1. Participant’s Overview
7.5.7.2. Financial Performance
7.5.7.3. Product Benchmarking
7.5.7.4. Recent Developments/ Strategic Initiatives
7.5.8. GSK plc.
7.5.8.1. Participant’s Overview
7.5.8.2. Financial Performance
7.5.8.3. Product Benchmarking
7.5.8.4. Recent Developments/ Strategic Initiatives
7.5.9. Sanofi
7.5.9.1. Participant’s Overview
7.5.9.2. Financial Performance
7.5.9.3. Product Benchmarking
7.5.9.4. Recent Developments/ Strategic Initiatives
7.5.10. Bayer AG
7.5.10.1. Participant’s Overview
7.5.10.2. Financial Performance
7.5.10.3. Product Benchmarking
7.5.10.4. Recent Developments/ Strategic Initiatives

List of Tables
Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. Global Immunotherapy Drugs Market, by Region, 2018 - 2030 (USD Million)
Table 4. Global Immunotherapy Drugs Market, by Drug Type, 2018 - 2030 (USD Million)
Table 5. North America Immunotherapy Drugs Market, by Country, 2018 - 2030 (USD Million)
Table 6. North America Immunotherapy Drugs Market, by Drug Type, 2018 - 2030 (USD Million)
Table 7. U.S. Immunotherapy Drugs Market, by Drug Type, 2018 - 2030 (USD Million)
Table 8. Canada Immunotherapy Drugs Market, by Drug Type, 2018 - 2030 (USD Million)
Table 9. Mexico Immunotherapy Drugs Market, by Drug Type, 2018 - 2030 (USD Million)
Table 10. Europe Immunotherapy Drugs Market, by Country, 2018 - 2030 (USD Million)
Table 11. Europe Immunotherapy Drugs Market, by Drug Type, 2018 - 2030 (USD Million)
Table 12. Germany Immunotherapy Drugs Market, by Drug Type, 2018 - 2030 (USD Million)
Table 13. UK Immunotherapy Drugs Market, by Drug Type, 2018 - 2030 (USD Million)
Table 14. France Immunotherapy Drugs Market, by Drug Type, 2018 - 2030 (USD Million)
Table 15. Italy Immunotherapy Drugs Market, by Drug Type, 2018 - 2030 (USD Million)
Table 16. Spain Immunotherapy Drugs Market, by Drug Type, 2018 - 2030 (USD Million)
Table 17. Sweden Immunotherapy Drugs Market, by Drug Type, 2018 - 2030 (USD Million)
Table 18. Denmark Immunotherapy Drugs Market, by Drug Type, 2018 - 2030 (USD Million)
Table 19. Norway Immunotherapy Drugs Market, by Drug Type, 2018 - 2030 (USD Million)
Table 20. Asia Pacific Immunotherapy Drugs Market, by Country, 2018 - 2030 (USD Million)
Table 21. Asia Pacific Immunotherapy Drugs Market, by Drug Type, 2018 - 2030 (USD Million)
Table 22. China Immunotherapy Drugs Market, by Drug Type, 2018 - 2030 (USD Million)
Table 23. Japan Immunotherapy Drugs Market, by Drug Type, 2018 - 2030 (USD Million)
Table 24. India Immunotherapy Drugs Market, by Drug Type, 2018 - 2030 (USD Million)
Table 25. South Korea Immunotherapy Drugs Market, by Drug Type, 2018 - 2030 (USD Million)
Table 26. Australia Immunotherapy Drugs Market, by Drug Type, 2018 - 2030 (USD Million)
Table 27. Thailand Immunotherapy Drugs Market, by Drug Type, 2018 - 2030 (USD Million)
Table 28. Latin America Immunotherapy Drugs Market, by Country, 2018 - 2030 (USD Million)
Table 29. Latin America Immunotherapy Drugs Market, by Drug Type, 2018 - 2030 (USD Million)
Table 30. Brazil Immunotherapy Drugs Market, by Drug Type, 2018 - 2030 (USD Million)
Table 31. Argentina Immunotherapy Drugs Market, by Drug Type, 2018 - 2030 (USD Million)
Table 32. Middle East & Africa Immunotherapy Drugs Market, by Country, 2018 - 2030 (USD Million)
Table 33. Middle East & Africa Immunotherapy Drugs Market, by Drug Type, 2018 - 2030 (USD Million)
Table 34. South Africa Immunotherapy Drugs Market, by Drug Type, 2018 - 2030 (USD Million)
Table 35. Saudi Arabia Immunotherapy Drugs Market, by Drug Type, 2018 - 2030 (USD Million)
Table 36. UAE Immunotherapy Drugs Market, by Drug Type, 2018 - 2030 (USD Million)
Table 37. Kuwait Immunotherapy Drugs Market, by Drug Type, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Immunotherapy drugs market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Segment outlook (USD Million)
Fig. 10 Competitive landscape
Fig. 11 Immunotherapy drugs market dynamics
Fig. 12 Immunotherapy drugs market: Porter’s five forces analysis
Fig. 13 Immunotherapy drugs market: PESTLE analysis
Fig. 14 Immunotherapy drugs market: Drug type segment dashboard
Fig. 15 Immunotherapy drugs market: Drug type market share analysis, 2024 & 2030
Fig. 16 Monoclonal antibodies market, 2018 - 2030 (USD Million)
Fig. 17 Immunomodulator market, 2018 - 2030 (USD Million)
Fig. 18 Vaccine market, 2018 - 2030 (USD Million)
Fig. 19 Immunotherapy drugs market: Indication segment dashboard
Fig. 20 Immunotherapy drugs market: Indication market share analysis, 2024 & 2030
Fig. 21 Cancer market, 2018 - 2030 (USD Million)
Fig. 22 Autoimmune diseases market, 2018 - 2030 (USD Million)
Fig. 23 Infectious diseases market, 2018 - 2030 (USD Million)
Fig. 24 Others market, 2018 - 2030 (USD Million)
Fig. 25 Immunotherapy drugs market revenue, by region
Fig. 26 Regional marketplace: Key takeaways
Fig. 27 North America immunotherapy drugs market, 2018 - 2030 (USD Million)
Fig. 28 U.S. country dynamics
Fig. 29 U.S. immunotherapy drugs market, 2018 - 2030 (USD Million)
Fig. 30 Canada country dynamics
Fig. 31 Canada immunotherapy drugs market, 2018 - 2030 (USD Million)
Fig. 32 Mexico country dynamics
Fig. 33 Mexico immunotherapy drugs market, 2018 - 2030 (USD Million)
Fig. 34 Europe immunotherapy drugs market, 2018 - 2030 (USD Million)
Fig. 35 UK country dynamics
Fig. 36 UK immunotherapy drugs market, 2018 - 2030 (USD Million)
Fig. 37 Germany country dynamics
Fig. 38 Germany immunotherapy drugs market, 2018 - 2030 (USD Million)
Fig. 39 France country dynamics
Fig. 40 France immunotherapy drugs market, 2018 - 2030 (USD Million)
Fig. 41 Italy country dynamics
Fig. 42 Italy immunotherapy drugs market, 2018 - 2030 (USD Million)
Fig. 43 Spain country dynamics
Fig. 44 Spain immunotherapy drugs market, 2018 - 2030 (USD Million)
Fig. 45 Denmark country dynamics
Fig. 46 Denmark immunotherapy drugs market, 2018 - 2030 (USD Million)
Fig. 47 Sweden country dynamics
Fig. 48 Sweden immunotherapy drugs market, 2018 - 2030 (USD Million)
Fig. 49 Norway country dynamics
Fig. 50 Norway immunotherapy drugs market, 2018 - 2030 (USD Million)
Fig. 51 Asia Pacific immunotherapy drugs market, 2018 - 2030 (USD Million)
Fig. 52 Japan country dynamics
Fig. 53 Japan immunotherapy drugs market, 2018 - 2030 (USD Million)
Fig. 54 China country dynamics
Fig. 55 China immunotherapy drugs market, 2018 - 2030 (USD Million)
Fig. 56 India country dynamics
Fig. 57 India immunotherapy drugs market, 2018 - 2030 (USD Million)
Fig. 58 Thailand country dynamics
Fig. 59 Thailand immunotherapy drugs market, 2018 - 2030 (USD Million)
Fig. 60 South Korea country dynamics
Fig. 61 South Korea immunotherapy drugs market, 2018 - 2030 (USD Million)
Fig. 62 Australia country dynamics
Fig. 63 Australia immunotherapy drugs market, 2018 - 2030 (USD Million)
Fig. 64 Latin America immunotherapy drugs market, 2018 - 2030 (USD Million)
Fig. 65 Brazil country dynamics
Fig. 66 Brazil immunotherapy drugs market, 2018 - 2030 (USD Million)
Fig. 67 Argentina country dynamics
Fig. 68 Argentina immunotherapy drugs market, 2018 - 2030 (USD Million
Fig. 69 MEA immunotherapy drugs market, 2018 - 2030 (USD Million)
Fig. 70 South Africa country dynamics
Fig. 71 South Africa immunotherapy drugs market, 2018 - 2030 (USD Million)
Fig. 72 Saudi Arabia country dynamics
Fig. 73 Saudi Arabia immunotherapy drugs market, 2018 - 2030 (USD Million)
Fig. 74 UAE country dynamics
Fig. 75 UAE immunotherapy drugs market, 2018 - 2030 (USD Million)
Fig. 76 Kuwait country dynamics
Fig. 77 Kuwait immunotherapy drugs market, 2018 - 2030 (USD Million)
Fig. 78 Company categorization
Fig. 79 Company market position analysis
Fig. 80 Strategic framework